Evidence map›Paper›PMID 36357290›Full record

ArticleVaccine2022

Strategies to increase the intention to get vaccinated against COVID-19: Findings from a nationally representative survey of US adults, October 2020 to October 2021.

Arash Naeim, Rebecca J Guerin, Ryan Baxter-King, Andrea H Okun, Neil Wenger, Karen Sepucha, Annette L Stanton, Aaron Rudkin, Derek Holliday, Alexander Rossell Hayes and 1 more

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Arash NaeimCenter for SMART Health, Clinical and Translational Science Institute, University of California, Los Angeles, United States. Electronic address: anaeim@mednet.ucla.edu.
Rebecca J GuerinDivision of Science Integration, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, United States.
Ryan Baxter-KingDepartment of Political Science, University of California, Los Angeles, United States.
Andrea H OkunDivision of Science Integration, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, United States.
Neil WengerDivision of General Internal Medicine and Health Sciences Research, David Geffen School of Medicine at UCLA, United States.
Karen SepuchaHealth Decision Sciences Center, Massachusetts General Hospital, Harvard Medical School, United States.
Annette L StantonDepartments of Psychology and Psychiatry/Biobehavioral Sciences, UCLA, United States.
Aaron RudkinDepartments of Political Science, Trinity College, Dublin, Ireland; Department of Political Science, University of California, Los Angeles, United States.
Derek HollidayDepartment of Political Science, University of California, Los Angeles, United States.
Alexander Rossell HayesDepartment of Political Science, University of California, Los Angeles, United States.
Lynn VavreckDepartments of Political Science and Communication, University of California, Los Angeles, United States.
University of California, Los Angeles · USCenters for Disease Control and Prevention · USMassachusetts General Hospital · USNeurobehavioral Systems · USSMART Global Holdings (United States) · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
NCATS NIH HHS UL1 TR001881
6 · The paper itself

Abstract

objectivesWe examined COVID-19 vaccination status, intention, and hesitancy and the effects of five strategies to increase the willingness of unvaccinated adults (≥18 years) to get a COVID vaccine.

methodsOnline surveys were conducted between October 1-17, 2020 (N = 14,946), December 4-16, 2020 (N = 15,229), April 8-22, 2021 (N = 14,557), June 17-July 6, 2021 (N = 30,857), and September 3-October 4, 2021 (N = 33,088) with an internet-based, non-probability opt-in sample of U.S. adults matching demographic quotas. Respondents were asked about current COVID-19 vaccination status, intention and hesitancy to get vaccinated, and reasons for vaccine hesitancy. Unvaccinated respondents were assigned to treatment groups to test the effect of five strategies (endorsements, changing social restrictions, financial incentives, vaccine requirements for certain activities, and vaccine requirements for work). Chi-square tests of independence were performed to detect differences in the response distributions.

resultsWillingness to be vaccinated (defined as being vaccinated or planning to be) increased over time from 47.6 % in October 2020 to 81.1 % in October 2021. By October 2021, across most demographic groups, over 75 % of survey respondents had been or planned to be vaccinated. In terms of strategies: (1) endorsements had no positive effect, (2) relaxing the need for masks and social distancing increased Intention to Get Vaccinated (IGV) by 6.4 % (p < 0.01), (3) offering financial incentives increased the IGV between 12.3 and 18.9 % (p <.001), (4) vaccine requirements for attending sporting events or traveling increased IGV by 7.8 % and 9.1 %, respectively (p = 0.02), and vaccine requirement for work increased IGV by 35.4 %. The leading causes (not mutually exclusive) for hesitancy were concerns regarding vaccine safety (52.5 %) or side effects (51.6 %), trust in the government's motives (41.0 %), and concerns about vaccine effectiveness (37.6 %).

conclusionsThese findings suggest that multiple strategies may be effective and needed to increase COVID-19 vaccination among hesitant adults during the pandemic.

Indexed as

COVID-19IntentionAdultCOVID-19 VaccinesHumansPhysical DistancingSurveys and QuestionnairesVaccinationCOVID-19 Vaccines

Identifiers

PMID36357290
PMCPMC9464582
OpenAlexW4297812291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.